The endocrinological component and signaling pathways associated to cardiac hypertrophy

Autor(es)

Cremasco Takano, Ana Paula ^[1] ; Senger, Nathalia ^[1] ; Barreto-Chaves, Maria Luiza M. ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Molecular and Cellular Endocrinology; v. 518, DEC 1 2020.
• Citações Web of Science: 1

Resumo

Although myocardial growth corresponds to an adaptive response to maintain cardiac contractile function, the cardiac hypertrophy is a condition that occurs in many cardiovascular diseases and typically precedes the onset of heart failure. Different endocrine factors such as thyroid hormones, insulin, insulin-like growth factor 1 (IGF-1), angiotensin II (Ang II), endothelin (ET-1), catecholamines, estrogen, among others represent important stimuli to cardiomyocyte hypertrophy. Thus, numerous endocrine disorders manifested as changes in the local environment or multiple organ systems are especially important in the context of progression from cardiac hypertrophy to heart failure. Based on that information, this review summarizes experimental findings regarding the influence of such hormones upon signalling pathways associated with cardiac hypertrophy. Understanding mechanisms through which hormones differentially regulate cardiac hypertrophy could open ways to obtain therapeutic approaches that contribute to prevent or delay the onset of heart failure related to endocrine diseases. (AU)

• Processo FAPESP: 19/06435-5 - Mecanismos celulares e moleculares envolvidos no envelhecimento cardíaco: efeitos da supressão específica de NF-kB em cardiomiócitos
• Beneficiário: Ana Paula Cremasco Takano
• Modalidade de apoio: Auxílio à Pesquisa - Regular